Showing results (611-620 of 735) with videos related to

Sort By:
Pageof 74
Insights Into Imaging|April 15, 2023
A deep learning model using chest X-ray for identifying TB and NTM-LD patients: a cross-sectional studyChia-Jung Liu, Cheng Che Tsai, Lu-Cheng Kuo, et al.
Journal of Medical Systems|December 4, 2023
Deep Learning-based Diagnosis and Localization of Pneumothorax on Portable Supine Chest X-ray in Intensive and Emergency Medicine: A Retrospective StudyChih-Hung Wang, Tzuching Lin, Guanru Chen, et al.
Emerging Microbes & Infections|April 22, 2025
Prevalence and treatment outcomes of latent tuberculosis infection among older patients with chronic obstructive pulmonary disease in an area with intermediate tuberculosis burdenHung-Ling Huang, Meng-Hsuan Cheng, Meng-Rui Lee, et al.
The Lancet. Oncology|March 29, 2012
Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trialJames Chih-Hsin Yang, Jin-Yuan Shih, Wu-Chou Su, et al.
American Journal of Respiratory and Critical Care Medicine|July 19, 2014
Shisa3 is associated with prolonged survival through promoting β-catenin degradation in lung cancerChun-Chieh Chen, Hsuan-Yu Chen, Kang-Yi Su, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 2013
Virological, serological, and antiviral studies in an imported human case of avian influenza A(H7N9) virus in TaiwanPi-Han Lin, Tai-Ling Chao, Shuenn-Wen Kuo, et al.
Journal of Biomedical Science|February 5, 2016
Fanconi anemia genes in lung adenocarcinoma- a pathway-wide study on cancer susceptibilityShi-Yi Yang, Chia-Ni Hsiung, Yao-Jen Li, et al.
ESMO Open|December 7, 2017
Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancerFiona Blackhall, D Ross Camidge, Alice T Shaw, et al.
Annals of Surgical Oncology|September 30, 2006
A gene expression profile for vascular invasion can predict the recurrence after resection of hepatocellular carcinoma: a microarray approachMing-Chih Ho, Jen-Jen Lin, Chiung-Nien Chen, et al.
Frontiers in Oncology|July 18, 2022
Compassionate Use of Ripretinib for Patients With Metastatic Gastrointestinal Stromal Tumors: Taiwan and Hong Kong ExperienceLi-Ching Lin, Wen-Kuan Huang, Chueh-Chuan Yen, et al.
Pageof 74